Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?프로바이오틱스는 과체중 및 비만 성인의 상기도 감염의 자가 보고된 증상을 감소시킵니다. 바이러스 전염병 동안 프로바이오틱스를 고려해야 합니까?Research Article Published on 2021-03-252022-08-13 Journal: Gut Microbes [Category] 임상, [키워드] addendum Alter Analysis BMI children clinical trial clinical trials comparable COVID-19 greater gut microbiome Gut microbiome manipulation gut-lung axis healthy Human increased risk Infection metabolic parameters obese obesity Occurrence overweight/obese Participants placebo-controlled trial Probiotics promise PROTECT reduce reduction reduction in remained respiratory respiratory infections self-reported symptom study participant Study participants Support Symptom the gut-lung axis Trial upper respiratory tract upper respiratory tract infection URTI URTI symptom URTI symptoms Viral viral upper respiratory tract infections viral URTI weight weight loss [DOI] 10.1080/19490976.2021.1900997 PMC 바로가기 [Article Type] Research Article
Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 InfectionReview Published on 2021-03-232023-06-15 Journal: Chemotherapy [Category] MERS, [키워드] COVID-19 Dysbiosis gut-lung axis Probiotics Systemic cytokine storm [DOI] 10.1159/000515344 PMC 바로가기 [Article Type] Review
Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?Commentary Published on 2021-02-252022-11-01 Journal: Gut Pathogens [Category] COVID-19, [키워드] accompanied acute respiratory distress Analysis angiotensin-converting enzyme 2 Bacterial bacterial co-infection COVID-19 COVID-19 disease COVID-19 infection COVID-19 patients cross talk effective gastrointestinal symptoms Gut gut microbiota gut-lung axis Gut-microbiome immune reaction immune response implication Infection infections lung management Microbiome microbiota nasopharyngeal Opportunistic Pathogens organ pathogen Probiotics Prognosis provide pulmonary disease rectal swab regulated SARS-CoV-2 severity Stool Swab syndrome therapy Treatment [DOI] 10.1186/s13099-021-00407-7 PMC 바로가기 [Article Type] Commentary
Microbiota Modulation of the Gut-Lung Axis in COVID-19COVID-19에서 장폐 축의 미생물총 조절Review Published on 2021-02-242022-09-11 Journal: Frontiers in Immunology [Category] MERS, 치료기술, 치료제, [키워드] addition administration Affect affected Anti-inflammatory axis bidirectional caused condition consequence correlated COVID-19 COVID-19 patients deaths deregulation diarrhea digestive Diversity duodenum Dysbiosis exacerbated Fecal sample fecal samples gastrointestinal system gastrointestinal tract gastrointestinal tracts Gut gut microbiota gut-lung axis Health Organization immune immune response immune responses increased mortality Infectious disease Inflammation Interaction intestinal involved lung Lungs manifestation Manifestations mechanism microbiota modulation mucosa mucosal mucous membrane mucous membranes nasopharyngeal oesophagus other respiratory infections pathologic persistence Probiotics Prolonged rectum Regulatory respiratory respiratory and gastrointestinal tracts respiratory infections respiratory mucosa Respiratory system SARS-CoV-2 SARS-CoV-2 clearance SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 stomach target the healthy Therapeutic approach therapy virus WHO World Health Organization [DOI] 10.3389/fimmu.2021.635471 PMC 바로가기 [Article Type] Review
Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver위장관과 간에 대한 SARS-CoV-2의 잠재적 영향Review Published on 2021-01-012022-09-11 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] SARS, 치료제, [키워드] abdominal pain ACE2 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 aetiology angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 caused clinically connection coronavirus cough COVID-19 cytokine Cytokine storm determine diarrhoea digestive digestive system Effect enzyme expressed Fever Gastrointestinal gastrointestinal tract gut-lung axis include Inflammatory cytokine storm liver Liver injury liver transplant mechanism pandemic Potential receptor reported reported symptom Research respiratory respiratory symptoms SARS-CoV-2 SARS-CoV-2 receptor severe acute respiratory syndrome Coronavirus suggested Symptom Symptoms the SARS-CoV-2 vomiting with COVID-19 [DOI] 10.1016/j.biopha.2020.111064 PMC 바로가기 [Article Type] Review
Hyponatremia: A possible immuno-neuroendocrine interface with COVID-19 in a kidney transplant recipientCase Reports Published on 2020-12-012023-07-13 Journal: Transplant infectious disease : an official journa [Category] SARS, [키워드] Coronavirus disease 2019 COVID-19 gastrointestinal symptoms gut-lung axis immuno-neuroendocrine interface Kidney transplantation [DOI] 10.1111/tid.13355 [Article Type] Case Reports
Gut Microbiota Status in COVID-19: An Unrecognized Player?Cellular and Infection Microbiology Published on 2020-11-262022-10-31 Journal: Frontiers in Cellular and Infection Microbiology [Category] COVID-19, MERS, SARS, [키워드] Affect alteration Bacterial Cardiopulmonary cause characterized clinical condition clinical implication Comorbidities Comorbidity complex complications Consequences Course COVID-19 Deleterious develop example fatality gut microbiota gut-lung axis Health status healthy influence influenza A Interaction intestinal majority Microbiome microbiota microbiota manipulating microbiota-virus interactions Particle pathogenic mechanism pharmacological polypharmacy preventive therapeutic strategies progression reduce regimen Resilience risk risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV2 infection severity status subject surface molecule susceptibility target the SARS-CoV-2 virus Treatment understanding variety Vascular viral infections virulence viruses [DOI] 10.3389/fcimb.2020.576551 PMC 바로가기 [Article Type] Cellular and Infection Microbiology
Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory DisordersReview Published on 2020-10-222022-10-30 Journal: Molecules [Category] COVID-19, MERS, SARS, [키워드] Activation Brain cause commensal bacteria COVID-19 COVID-19 disease Critical disease Diseases disorders disturbance gut microbiota Gut-brain axis gut-lung axis homeostasis Host host immune system illnesses immune dysfunction immune system Immunity immunomodulation induce Infection Inflammation inflammatory condition Influenza virus influenza virus infection intestine lung maintain Mental mental health modulating multiple sclerosis Neuroinflammation Neurological disorder non-infectious other organ Probiotics PROTECT public health crisis Research respiratory respiratory infection Support tissue damage Treatment viral respiratory infections [DOI] 10.3390/molecules25214891 PMC 바로가기 [Article Type] Review
Role of probiotics to combat viral infections with emphasis on COVID-19Article Published on 2020-08-192023-06-15 Journal: Applied Microbiology and Biotechnology [Category] MERS, SARS, [키워드] COVID-19 gut-lung axis Probiotics SARS-CoV-2 zoonosis [DOI] 10.1007/s00253-020-10832-4 PMC 바로가기
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19Medicine Published on 2020-07-072022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] added age All the patient Antibiotics Bacterial bacteriotherapy challenge clinical condition coded cohorts of patient Combination comparable complementary COVID-19 COVID-19 disease diarrhea disorder evaluate Fever Gastrointestinal Gut gut-lung axis Hospitalized Host Hydroxychloroquine ICU infecting Inflammation intestinal epithelial cells Laboratory lactobacillus less lung involvement microbial flora Mortality Non-invasive oral oxygen support Oxygen therapy Pathologies Patient patients treated positive Prevalence Probiotic progression receiving required Respiratory failure risk role SARS-CoV-2 SARS-COV-2 infection SARS-CoV2 Sex Strategy Stress subject supplemented group Symptom the gut-lung axis the patient therapeutic strategy therapy Tocilizumab transferred treated Treatment [DOI] 10.3389/fmed.2020.00389 PMC 바로가기 [Article Type] Medicine